Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses.

Rheumatol Ther · 2023 · PMC10654325 · PMID 37668865

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Only FIL200 + MTX showed nominally significant higher odds vs MTX monotherapy; FIL100 + MTX and FIL200 monotherapy did not.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.